These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35283513)

  • 1. Current Therapeutic Strategies of Xeroderma Pigmentosum.
    Hossain M; Hasan A; Shawan MMAK; Banik S; Jahan I
    Indian J Dermatol; 2021; 66(6):660-667. PubMed ID: 35283513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma pigmentosum: an updated review.
    Leung AK; Barankin B; Lam JM; Leong KF; Hon KL
    Drugs Context; 2022; 11():. PubMed ID: 35520754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide Excision Repair: From Molecular Defects to Neurological Abnormalities.
    Krasikova Y; Rechkunova N; Lavrik O
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma pigmentosum--bridging a gap between clinic and laboratory.
    Moriwaki S; Kraemer KH
    Photodermatol Photoimmunol Photomed; 2001 Apr; 17(2):47-54. PubMed ID: 11338401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
    Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
    Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sunlight, Vitamin D, and Xeroderma Pigmentosum.
    Martens MC; Emmert S; Boeckmann L
    Adv Exp Med Biol; 2020; 1268():319-331. PubMed ID: 32918226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic approaches to xeroderma pigmentosum.
    Weon JL; Glass DA
    Br J Dermatol; 2019 Aug; 181(2):249-255. PubMed ID: 30265743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xeroderma pigmentosum in Ghanaians: a report of three cases and review of literature.
    Adu EJ
    West Afr J Med; 2014; 33(1):82-5. PubMed ID: 24872274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Xeroderma pigmentosum].
    Takeuchi S
    Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xeroderma Pigmentosum - Facts and Perspectives.
    Lehmann J; Seebode C; Martens MC; Emmert S
    Anticancer Res; 2018 Feb; 38(2):1159-1164. PubMed ID: 29374753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
    Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
    Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeroderma pigmentosum: man deprived of his right to light.
    Mareddy S; Reddy J; Babu S; Balan P
    ScientificWorldJournal; 2013; 2013():534752. PubMed ID: 24459435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of Xeroderma pigmentosum variant.
    Gratchev A; Strein P; Utikal J; Sergij G
    Exp Dermatol; 2003 Oct; 12(5):529-36. PubMed ID: 14705792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Xeroderma pigmentosum].
    Ueda M; Ichihashi M
    Nihon Rinsho; 1995 Nov; 53(11):2815-20. PubMed ID: 8538050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
    Lambert WC; Lambert MW
    Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
    Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
    DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus-mediated DNA repair gene transfer into xeroderma pigmentosum cells: perspectives for a gene therapy.
    Zeng L; Sarasin A; Mezzina M
    Cell Biol Toxicol; 1998 Mar; 14(2):105-10. PubMed ID: 9553721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xeroderma pigmentosum: from genetics to hopes and realities of cutaneous gene therapy.
    Magnaldo T
    Expert Opin Biol Ther; 2004 Feb; 4(2):169-79. PubMed ID: 14998776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral-mediated correction of DNA repair defect in xeroderma pigmentosum cells is associated with recovery of catalase activity.
    Quilliet X; Chevallier-Lagente O; Zeng L; Calvayrac R; Mezzina M; Sarasin A; Vuillaume M
    Mutat Res; 1997 Dec; 385(3):235-42. PubMed ID: 9506892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.